Fig. 3.

In vivo biodistribution and clearance of AA-2G in colon-26 tumor-bearing CDF1 mice. AA-2G was injected intravenously into colon-26 tumor-bearing CDF1 mice. AA levels in the liver, kidney and tumor (A), AA level in plasma (B), AA-2G levels in tissues and plasma (C), and blood glucose level (D) after administration of AA-2G. All data represent means ± SE (n =4). A significant difference was found between kidney AA levels at 15 min and 0 min (A; P<0.05). Other significant differences are indicated in the figure (*P<0.05, each time point compared with that at 0 min).